Neuroimaging in former preterm children who received erythropoiesis stimulating agents
- PMID: 28553989
- PMCID: PMC5599329
- DOI: 10.1038/pr.2017.130
Neuroimaging in former preterm children who received erythropoiesis stimulating agents
Abstract
BackgroundIn premature children, erythropoiesis-stimulating agents (ESAs) may improve developmental outcome. It is not clear which of the several potential mechanisms are responsible for this improvement. High-resolution MRI and diffusion tensor imaging characterize brain structure and white matter organization, offering possible insight into the long-term effect of ESAs on brain development.MethodsMRI scans were performed at 3.5-4 years of age on former preterm infants treated with ESAs or placebo, and on healthy term controls. Mean cortical thickness, surface area, and fractional anisotropy (FA) were compared across study groups, and were correlated with general IQ measures.ResultsUnivariate analysis found no significant effect of ESAs on cortical thickness (P=0.366), surface area (P=0.940), or FA (P=0.150); however, there was a greater increase in FA among ESA-treated girls. Group analysis found significant correlations between FA and Full-Scale IQ (P=0.044) and Verbal IQ (P=0.036), although there was no significant relationship between Full-Scale IQ and FA among just the preterm children.ConclusionESA treatment may have a preferential effect on white matter development in girls, although factors other than just whole-brain FA are involved in mediating cognitive outcome.
Conflict of interest statement
Figures


Similar articles
-
Altered white matter development in children born very preterm.Brain Struct Funct. 2018 Jun;223(5):2129-2141. doi: 10.1007/s00429-018-1614-4. Epub 2018 Jan 29. Brain Struct Funct. 2018. PMID: 29380120
-
Preschool Assessment of Preterm Infants Treated With Darbepoetin and Erythropoietin.Pediatrics. 2016 Mar;137(3):e20153859. doi: 10.1542/peds.2015-3859. Epub 2016 Feb 15. Pediatrics. 2016. PMID: 26908704 Free PMC article. Clinical Trial.
-
Longitudinal change in white matter in preterm infants without magnetic resonance imaging abnormalities: Assessment of serial diffusion tensor imaging and their relationship to neurodevelopmental outcomes.Brain Dev. 2017 Jan;39(1):40-47. doi: 10.1016/j.braindev.2016.07.007. Epub 2016 Aug 16. Brain Dev. 2017. PMID: 27543266
-
Darbepoetin Administration in Term and Preterm Neonates.Clin Perinatol. 2015 Sep;42(3):557-66. doi: 10.1016/j.clp.2015.04.016. Epub 2015 May 23. Clin Perinatol. 2015. PMID: 26250917 Free PMC article. Review.
-
Neuroprotective effects of erythropoiesis-stimulating agents in term and preterm neonates.Curr Opin Pediatr. 2014 Apr;26(2):139-45. doi: 10.1097/MOP.0000000000000077. Curr Opin Pediatr. 2014. PMID: 24535496 Free PMC article. Review.
Cited by
-
Effect of Early High-Dose Recombinant Human Erythropoietin on Behavior and Quality of Life in Children Aged 5 Years Born Very Preterm: Secondary Analysis of a Randomized Clinical Trial.JAMA Netw Open. 2022 Dec 1;5(12):e2245499. doi: 10.1001/jamanetworkopen.2022.45499. JAMA Netw Open. 2022. PMID: 36477478 Free PMC article. Clinical Trial.
-
Sex differences in brain connectivity and male vulnerability in very preterm children.Hum Brain Mapp. 2020 Feb 1;41(2):388-400. doi: 10.1002/hbm.24809. Epub 2019 Oct 6. Hum Brain Mapp. 2020. PMID: 31587465 Free PMC article.
-
Whether Erythropoietin can be a Neuroprotective Agent against Premature Brain Injury: Cellular Mechanisms and Clinical Efficacy.Curr Neuropharmacol. 2022 Mar 4;20(3):611-629. doi: 10.2174/1570159X19666210524154519. Curr Neuropharmacol. 2022. PMID: 34030616 Free PMC article. Review.
-
Diffusion Tensor Imaging Changes Do Not Affect Long-Term Neurodevelopment following Early Erythropoietin among Extremely Preterm Infants in the Preterm Erythropoietin Neuroprotection Trial.Brain Sci. 2021 Oct 16;11(10):1360. doi: 10.3390/brainsci11101360. Brain Sci. 2021. PMID: 34679424 Free PMC article.
-
The long-term effect of erythropoiesis stimulating agents given to preterm infants: a proton magnetic resonance spectroscopy study on neurometabolites in early childhood.Pediatr Radiol. 2018 Mar;48(3):374-382. doi: 10.1007/s00247-017-4052-1. Epub 2018 Jan 15. Pediatr Radiol. 2018. PMID: 29335880 Free PMC article.
References
-
- Blencowe H, Cousens S, Oestergaard MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012;379(9832):2162–72. - PubMed
-
- Hutchinson EA, De Luca CR, Doyle LW, et al. School-age outcomes of extremely preterm or extremely low birth weight children. Pediatrics. 2013;131(4):e1053–e1061. - PubMed
-
- Iwai M, Cao G, Yin W, et al. Erythropoietin promotes neuronal replacement through revascularization and neurogenesis after neonatal hypoxia/ischemia in rats. Stroke. 2007;38(10):2795–803. - PubMed
-
- Dzietko M, Felderhoff-Mueser U, Sifringer M, et al. Erythropoietin protects the developing brain against N-methyl-D-aspartate receptor antagonist neurotoxicity. Neurobiol Dis. 2004;15(2):177–87. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical